Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for medical industry professionals · Monday, March 8, 2021 · 536,494,273 Articles · 3+ Million Readers

Radiation Therapy Quality Assurance (QA) Phantoms Market Size to Reach Value of USD 36.4 Mn by 2028 | Increasing Demand for Phantoms for Tumor and Cancer Treatment will be the Key Factor Driving the Industry Growth, States Emergen Research

Key players operating in the Radiation Therapy Quality Assurance (QA) Phantoms market are Computerized Imaging Reference Systems, Inc., Fluke Biomedical, IBA Dosimetry, Modus Medical Devices Inc., PTW Freiburg GmbH, Standard Imaging Inc., Sun Nuclear Corporation, The Phantom Laboratory Inc., Gammex Inc., and Gold Standard Phantoms.

/EIN News/ -- Vancouver, British Columbia, Feb. 16, 2021 (GLOBE NEWSWIRE) -- The global radiation therapy quality assurance (QA) phantoms market size was USD 25.6 Million in 2020 and is expected to reach a market size of USD 36.4 Million by 2028 growing at a CAGR of 4.4%, as a result of major R&D initiatives driving steady revenue growth, according to latest analysis by Emergen Research. Application of quality assurance phantoms helps radiation physicists to reduce medical errors in treatment planning and dose level, which in turn increase remission rates while decreasing recurrence rates and complications. Hence, checking quality status of radiation therapy technology devices on a daily, monthly, and annual basis is of major importance before delivering a radiation dose.

Quality assurance phantoms are used for characterization and calibration of radiation devices. These phantoms are also used in verification and distribution of a planned dose to ensure effective patient treatment. Some major factors driving revenue growth of the global radiation therapy quality assurance (QA) phantoms market include rising demand for modern and more advanced technologies in tumor and cancer treatments and rising concerns among personnel in diagnostic imaging centers and radiation therapy centers for providing maximum patient safety solutions during radiation treatment. Major companies around the world are currently developing systemic therapy procedures to reduce risk probability and to help medical centers to provide better patient care.

Claim Your FREE Sample Copy with Table of content@

Further Key Findings in the Report:

  • In October 2020, PTW Freiburg GmbH and The Netherlands Cancer Institute – Antoni van Leeuwenhoek Hospital – signed a collaboration agreement to develop advanced EPID-based dosimetry solution for automated patient-specific quality assurance during radiotherapy treatment.
  • The brachytherapy segment is expected to register a CAGR of 4.6% in the global radiation therapy quality assurance (QA) phantoms market throughout the forecast period. This can be attributed to high prevalence of breast, lung and colorectal cancers in countries in the region.
  • North America is projected to register a revenue CAGR of 4.9% between 2021 and 2028. Robust presence of major medical technology companies and growing investment in technology research activities is a key factor fueling revenue growth of the market in this region.

Check Our Prices@
For the purpose of this report, Emergen Research has segmented the global radiation therapy quality assurance (QA) phantoms market based on technology, therapy, application, and region as follows:

  • Technology Outlook (Revenue: USD Million; 2020–-2028)
    • Linear Accelerators
    • Cobalt-60
    • High-Dose Radiation
    • Low-Dose Radiation
  •      Therapy Outlook (Revenue: USD Million; 2020–-2028)
  • Photon Beam Radiation Therapy
  • Advanced 3-D Conformal Radiation Therapy
  • Image Guided Radiation Therapy
  • Intensity-modulated radiation therapy
  • Volumetric Modulated Arc Therapy
  • Intraoperative Radiotherapy
  • Neutron Beam Therapy
  • Brachytherapy
  •     Application Outlook (Revenue: USD Million; 2020–-2028)
    • Prostate Cancer
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Head and Neck Cancers
    • Skin Cancer
    • Other

Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends:

  • Regional Outlook (Revenue: USD Million; 2020–-2028)
    • North America
      1. U.S.
      2. Canada
    • Europe
      1. Germany
      2. U.K.
      3. France
      4. BENELUX
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. Japan
      3. South Korea
      4. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Take a Look at our Related Reports:

Topical Drug Delivery Market By Product Form (Semi-Solid, Solid Formulations, Transdermal Products, and Liquid Formulations), By Route (Dermal, Ophthalmic, Nasal, Others), By End-Use (Hospitals, Home Healthcare, Clinics, Diagnostic Centers, Burn Center), and By Regions

Medical Smart Textiles Market By Technology (Textile Sensors, Wearable Technology), By Application (Surgery, Bio-Monitoring, Therapy, and Wellness), By End-use (Hospitals and Clinics, Medical Academic and Research Center), and By Region

Operating Room Management Solutions Market By Solution Type (Data management and communication solutions, Operating room supply management solutions, Anesthesia information management solutions, Operating room scheduling solutions, Performance management solutions), By Mode of Deployment (Ob-premises, Cloud-based), By End-Use (Hospitals, Ambulatory surgical centers), and By Region

Patient Registry Software Market By Delivery, By Database, By Registry Type, By Function, By Software Type (Integrated, Standalone), By End-use (Government & Third-Party Administrators, Pharmaceutical Companies, Hospitals, Research Centers, Others), and By Region, Forecast to 2027

Ambulatory EHR Market By Deployment (Cloud-based, On-premises), By Practice Size (Solo Practices, Large Practices, Small-medium-sized Practices), By Application, By End-use (Independent Centers, Hospital-owned Ambulatory Centers, Others), and By Region, Forecasts to 2027

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web:

Direct Line: +1 (604) 757-9756


Facebook | LinkedIn | Twitter | Blogs

Read Full Press Release:

Primary Logo

Powered by EIN News

EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release